Skip to main content

Hypoglycemia News

Related terms: Low Blood Sugar

FDA Warns of Smartwatches That Claim to Measure Glucose Levels

THURSDAY, Feb. 22, 2024 – The U.S. Food and Drug Administration has issued an advisory regarding smartwatches and smart rings that claim to track blood glucose levels. "Sellers of these smartwatches...

Don't Use Smartwatches That Claim to Measure Blood Sugar, FDA Warns

THURSDAY, Feb. 22, 2024 – Some Americans living with diabetes are using smartwatches and smart rings that claim to be able to track their blood sugar. However, such claims from any device that does...

Decision Support Tool Cuts Hypoglycemia Risk in Older Adults

WEDNESDAY, Oct. 11, 2023 – In a population of at-risk older patients, the use of a clinical decision support tool and shared decision-making can reduce the risk for hypoglycemia by nearly half,...

Minimally Processed Red Meat Can Work in Weight Loss Diet With Diabetes

THURSDAY, Sept. 14, 2023 – A normal-protein diet that excludes red meat and a high-protein diet that contains minimally processed lean beef are similarly effective at producing weight loss and...

Glycemic Control Superior With Semaglutide 25 and 50 mg in Type 2 Diabetes

FRIDAY, Aug. 4, 2023 – Once-daily semaglutide 25 mg or 50 mg is superior to 14 mg for glycemic control among adults with type 2 diabetes, according to a study published online June 25 in The Lancet....

Kombucha May Help Control Blood Sugar in Folks With Type 2 Diabetes

TUESDAY, Aug. 1, 2023 – Kombucha is a fermented tea that many folks believe offers numerous health benefits — and new research suggests they may be right. Though the study was small – 12 p...

FDA Medwatch Alert: Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of Glucagon® Emergency Kit Due to Loss of Potency

INDIANAPOLIS, Sept. 24, 2021 -- Eli Lilly and Company (NYSE: LLY) is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar (Glucagon for Injection, ...

Xeris Pharmaceuticals Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke Kit for the Treatment of Severe Hypoglycemia

First ready-to-use liquid glucagon available in a single-dose vial and syringe kit for rescue Gvoke HypoPen®, Gvoke® PFS, and Gvoke® Kit – three different administration options to accommodate pati...

FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes

Copenhagen, DK and Boston, MA, U.S. March 22, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company aspiring to deliver innovation with novel peptide therapeutics, an...

FDA Approves Gvoke (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia

CHICAGO--(BUSINESS WIRE)--Sep. 10, 2019-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize...

FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia

July 24, 2019 – The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be...

FDA Medwatch Alert: GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc: Recall - Detached Needles on Syringe

ISSUE: Novo Nordisk Inc. is recalling six batches of the GlucaGen HypoKit in the U.S. due to two customer complaints from the UK and Portugal involving detached needles on the syringe with Sterile...

FDA Medwatch Alert: Proglycem (diazoxide): Drug Safety Communication - Reports of Pulmonary Hypertension in Infants and Newborns

[Posted 07/16/2015] ISSUE:  FDA is warning that a serious lung condition called pulmonary hypertension, which is high pressure in the blood vessels leading to the lungs, has been reported in ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

glucagon